학술논문
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial
Document Type
Article
Author
Source
In Annals of Oncology February 2020 31(2):310-317
Subject
Language
ISSN
0923-7534